22 AGENT FOR TREATMENT OF DRY EYE CHARACTERIZED BY COMBINING P2Y2 RECEPTOR AGONIST AND HYALURONIC ACID OR SALT THEREOF METHOD FOR TREATING DRY EYE AND USE OF THE 22 RECEPTOR AGONIST AND HYALURONIC ACID OR SALT THEREOF

摘要

A dry eye treatment agent characterized by a combination of a therapeutically effective concentration of a P2Y ₂ receptor agonist and a therapeutically effective concentration of hyaluronic acid or a salt thereof as a dry eye therapeutic agent, wherein the formulation is an ophthalmic solution, significantly accelerates leakage of the liquid, Is expected to become a new dry eye treatment.